What Does This Company Do?
Bioheart, Inc., is a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage, Cardio vascular disease and variety of degenerative diseases.
S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard.
© Copyright Morningstar, Inc